Daniel Streblow, Ph.D., in the Streblow lab inside VTGI at ONPRC on Fri., Dec. 2, 2022. The focus of the Streblow laboratory is on defining the role of human cytomegalovirus (HCMV) in the development of vascular disease and chronic rejection of organ allografts. The role of CMV in these diseases is still uncharacterized. (OHSU/Christine Torres Hicks)
